CHINA PHARMA HOLDINGS, INC. Common Stock, Value, Issued
CHINA PHARMA HOLDINGS, INC. (CPHI) had Common Stock, Value, Issued of $40.52 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-14
- 2026-06-30: Common Stock, Value, Issued $40.52K.
- 2026-03-31: Common Stock, Value, Issued $40.52K.
- 2025-12-31: Common Stock, Value, Issued $15.52K.
- 2025-09-30: Common Stock, Value, Issued $5.02K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $40.52K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $40.52K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $15.52K 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $5.02K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $3.26K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $3.26K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $3.26K 10-K · filed 2026-04-01 | $32.62K 10-K · filed 2025-03-31 |
| 2024-09-30 | $17.86K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $17.16K 10-Q · filed 2024-08-14 | |
| 2023-12-31 | $10.63K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $104.77K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $87.47K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $84.50K 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $1.50K 10-K · filed 2024-04-01 | $74.91K 10-K · filed 2023-03-30 |
| 2022-09-30 | $50.45K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $49.31K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $48.30K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $47.34K 10-K · filed 2023-03-30 | |
| 2021-09-30 | $47.34K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $45.58K 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $45.58K 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $45.58K 10-K · filed 2022-03-30 | |
| 2020-09-30 | $43.58K 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $43.58K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $43.58K 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $43.58K 10-K · filed 2021-03-26 | |
| 2019-09-30 | $43.58K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $43.58K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $43.58K 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $43.58K 10-K · filed 2020-03-30 | |
| 2018-09-30 | $43.58K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $43.58K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $43.58K 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $43.58K 10-K · filed 2019-03-28 | |
| 2017-09-30 | $43.58K 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $43.58K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $43.58K 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $43.58K 10-K · filed 2018-04-02 | |
| 2016-09-30 | $43.58K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $43.58K 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $43.58K 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $43.58K 10-K · filed 2017-03-31 | |
| 2015-09-30 | $43.58K 10-Q · filed 2015-12-28 | |
| 2015-06-30 | $43.58K 10-Q · filed 2015-12-28 | |
| 2015-03-31 | $43.58K 10-Q · filed 2015-12-28 | |
| 2014-12-31 | $43.58K 10-K · filed 2016-03-30 | |
| 2014-09-30 | $43.58K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $43.58K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $43.58K 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $43.58K 10-K · filed 2015-12-28 | |
| 2013-09-30 | $43.58K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $43.58K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $43.58K 10-Q · filed 2013-05-14 | |
| 2012-12-31 | $43.58K 10-K · filed 2014-03-20 | |
| 2012-09-30 | $43.58K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $43.58K 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $43.53K 10-Q · filed 2012-05-14 | |
| 2011-12-31 | $43.53K 10-K · filed 2013-03-14 | |
| 2011-09-30 | $43.53K 10-Q/A · filed 2012-03-06 | |
| 2011-06-30 | $43.53K 10-Q/A · filed 2011-09-06 | |
| 2010-12-31 | $43.41K 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |